Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.
Options
BORIS DOI
Date of Publication
 March 15, 2017 
Publication Type
Article
Division/Institute
Contributor
| Siddharta, Anindya | |
| Friesland, Martina | |
| Becker, Britta | |
| Yang, Jaewon | |
| Engelmann, Michael | |
| Todt, Daniel | |
| Windisch, Marc P | |
| Brill, Florian H | |
| Steinmann, Joerg | |
| Steinmann, Jochen | |
| Becker, Stephan | |
| Pietschmann, Thomas | |
| Eickmann, Markus | |
| Steinmann, Eike | 
Series
Journal of infectious diseases
ISSN or ISBN (if monograph)
0022-1899
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
28453839
Uncontrolled Keywords
Description
The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| jix046.pdf | text | Adobe PDF | 606.74 KB | published |